أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - glucose - anhydrous; glucose -

إسرائيل - الإنجليزية - Ministry of Health

teva medical marketing ltd. - glucose as monohydrate - solution for injection - glucose as monohydrate 10 % - glucose - glucose - as intravenous injection: dextrose 10 % injection is indicated as a source of water and calories. as parenteral nutrient: dextrose 10 % injection is indicated as a caloric component in parenteral nutrition regimen. it is used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1) the alimentary tract cannot should not be used. 2) gastrointestinal absorption of protein is impaired, or 3) metabolic requirements for protein are substantially increased, as extensive burns.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - glucose monohydrate 55 g/l;   - solution for infusion - 5 % - active: glucose monohydrate 55 g/l   excipient: hydrochloric acid sodium hydroxide water for injection

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - potassium acetate, quantity: 1.28 g/l; sodium chloride, quantity: 2.34 g/l; magnesium acetate tetrahydrate, quantity: 320 mg/l; glucose, quantity: 50 g/l - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid - plasma-lyte 56 and 5% glucose iv infusion is indicated as a source of water, electrolytes and calories or as an alkalinising agent. plasma-lyte 56 in 5% glucose is indicated as a source of water and electrolytes or as an alkalinising agent.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium nitroprusside, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - sodium nitroprusside baxter concentrated injection is indicated for:,1. immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.,2. producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.,3. short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - glucose, quantity: 500 mg/ml - injection, solution - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 20 may 1996 : sever hypoglycaemia resulting from insulin excess. glucose injection (50%) is strongly hypertonic and may be used for its dehydrating effects. being hypertonic, it is administered to promote diuresis, reduce increased cerebrospinal pressure and or impending cerebral oedema due to delirium tremens or acute alcoholic intoxication, glucose (50%) may also be used as a sclerosing agent in the treatment of varicose veins, however recanalisttion and pulmonary embolism are likely to occur.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - alfentanil hydrochloride, quantity: 5.44 mg (equivalent: alfentanil, qty 5 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride - alfentanil injection is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil (as hydrochloride) is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil (as hydrochloride) is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil (as hydrochloride) or by adapting the infusion rate.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - alfentanil hydrochloride, quantity: 1.09 mg (equivalent: alfentanil, qty 1 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride - alfentanil injection is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil (as hydrochloride) is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil (as hydrochloride) is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil (as hydrochloride) or by adapting the infusion rate.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - indications ast at 24 june 2004: for relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm. bricanyl injection: bricanyl injection solution is recommended for acute use only.

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - glucose anhydrous - solution for injection - 100mg/1gram